Upwork Reports Second Quarter 2025 Financial Results GlobeNewswire August 07, 2025 Achieves record second quarter with revenue of $194.9 millionGenerates GAAP net income of $32.7 million and adjusted EBITDA of $57.1 million, resulting in 17% profit margin and 29% adjusted EBITDA marginRaises FY2025 revenue and adjusted EBITDA guidanceAcquires Bubty and agrees to acquire Ascen to […]
Verano Announces Second Quarter 2025 Financial Results GlobeNewswire August 07, 2025 CHICAGO, Aug. 07, 2025 (GLOBE NEWSWIRE) — Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced its financial results for the second quarter ended June 30, 2025, which were prepared in accordance with U.S.
Tecnoglass Reports Record Second Quarter 2025 Results GlobeNewswire August 07, 2025 – Record Quarterly Revenue of $255.5 Million, Up 16.3% Year-Over-Year with Double Digit Organic Growth in Both Single-Family Residential and Multi-Family/Commercial Businesses –– Single-Family Residential Revenue Achieved a Second Quarter Record of $109.6 Million, Up 14.5% Year-Over-Year –– Single-Family Residential Orders Grew 29.0% Sequentially,
Xali Gold Trading Halt GlobeNewswire August 07, 2025 VANCOUVER, British Columbia, Aug. 07, 2025 (GLOBE NEWSWIRE) — Xali Gold Corp. (TSXV: XGC) (“Xali Gold” or “the Company”) advises that the British Columbia Securities Commission has notified the Company that it has issued a cease trade order (“FFCTO”) under Multilateral Instrument 11-103 – Failure-to-File Cease Trade
CorMedix to acquire Melinta Therapeutics, Creating Diversified Specialty Company With Strong Presence in Acute Care Settings GlobeNewswire August 07, 2025 Transformational deal for CorMedix that expands and diversifies company's commercial product portfolio, with seven innovative drug products and a pipeline expansion indication with near-term revenue growth potential Transaction expected to be near-term accretive to EPS
XORTX Provides Corporate Update and Planned Activities for 2025 / 2026 GlobeNewswire August 07, 2025 CALGARY, Alberta, Aug. 07, 2025 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company“) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney
Cormedix Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update GlobeNewswire August 07, 2025 â€' Q2 2025 Net Revenue of $39.7mm; Net Income of $19.8mm; Adjusted EBITDA of $22.4mm â€' â€' Company Announces Acquisition of Melinta Therapeutics â€' â€' Conference Call Scheduled for Today at 8:30 a.m. Eastern Time â€' BERKELEY HEIGHTS, N.J.,
Cipher Mining Provides Second Quarter 2025 Business Update GlobeNewswire August 07, 2025 Second Quarter 2025 Revenue of $44m and Non-GAAP Adjusted Earnings of $30m Black Pearl Phase I exceeds growth targets, bringing Cipher's total self-mining capacity to ~16.8 EH/s and on track to deliver ~23.5 EH/s by the end of the third quarter 2025 NEW
EnWave Corporation Announces LIFE Offering Private Placement of up to $3 Million GlobeNewswire August 07, 2025 Not for distribution to United States newswire services or for dissemination in the United States VANCOUVER, British Columbia, Aug. 07, 2025 (GLOBE NEWSWIRE) — EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) is pleased to announce that it
Akebia Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights GlobeNewswire August 07, 2025 Continued Vafseo(R) (vadadustat) growth with Q2 2025 net product revenues increasing to $13.3 million; Total Q2 2025 net product revenues increased to $60.5 million DaVita physicians are expected to begin treating patients with Vafseo in August 2025 as part